Skip to search formSkip to main contentSkip to account menu

Antineoplastic Agent Combination SM-88

Known as: SM-88 
An orally bioavailable, proprietary combination of four agents with potential antineoplastic activity. Although the four agents and their exact… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The novel drug SM-88 seems to be a promising therapy for previously treated patients with advanced pancreatic ductal… 
2018
2018
Researchers reported promising safety data from an ongoing phase Ib/II clinical trial for SM-88, an investigational combination…